[{"id":"77153b61-c254-4d36-83e7-366b559ddf6c","acronym":"Capella","url":"https://clinicaltrials.gov/study/NCT05493800","created_at":"2022-08-09T17:04:52.927Z","updated_at":"2024-07-02T16:35:00.581Z","phase":"Phase 2","brief_title":"Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT","source_id_and_acronym":"NCT05493800 - Capella","lead_sponsor":"MitoImmune Therapeutics","biomarkers":" CD34","pipe":"","alterations":" ","tags":["CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MIT-001"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 02/01/2022","start_date":" 02/01/2022","primary_txt":" Primary completion: 06/30/2024","primary_completion_date":" 06/30/2024","study_txt":" Completion: 12/30/2024","study_completion_date":" 12/30/2024","last_update_posted":"2024-05-29"}]